Skip to content

Clinical trials

Terminated Phase 2 Hemorrhage trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 2 Status: Terminated Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20111
20121
20131
20141
20153
20161
20171
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre Hospitalier Universitaire de Saint Etienne1
Corewell Health East1
Daniel Zimpfer, MD1
GlaxoSmithKline1
IRCCS Policlinico S. Donato1
Indiana University1
Johns Hopkins University1
Mallinckrodt1
McMaster University1
Northwell Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage14
Thrombocytopenia2
Afibrinogenemia1
Cerebral Hemorrhage1
Edema1
Heart Defects, Congenital1
Hemophilia B1
Pain1
Postoperative Hemorrhage1
Postoperative Pain1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.